Oncology has seen growing use of newly developed targeted therapies. Although this has
resulted in dramatic improvements in progression-free and overall survival, challenges in …

Chemotherapy and targeted therapies have significantly improved the prognosis of
oncology patients. However, these antineoplastic treatments may also induce adverse …

The reductions in mortality and morbidity being achieved among cancer patients with current
therapies represent a major achievement. However, given their mechanisms of action, many …

While anti‐cancer therapies, including chemotherapy, immunotherapy, radiotherapy, and
targeted therapy, are constantly advancing, cardiovascular toxicity has become a major …

Advances in cancer therapy have resulted in significant improvement in long-term survival
for many types of cancer but have also resulted in untoward side effects associated with …

Over the past decade, evolving cancer treatments have resulted in improved overall survival.
It is estimated that there are approximately 15 million cancer survivors in the United States …

Success with oncologic treatment has allowed cancer patients to experience longer cancer-
free survival gains. Unfortunately, this success has been tempered by unintended and often …

Cancer therapies, especially anthracyclines and monoclonal antibodies, have been linked
with increased rates of cardiotoxicity. The development of some cardiac side effects …

Cardio-oncology is a new field of interest in cardiology that focuses on the detection,
monitoring, and treatment of cardiovascular disease occurring as a side effect of …

Abstract Purpose of Review Cardiotoxicity is an important complication of cancer therapy.
With a significant improvement in the overall survival and prognosis of patients undergoing …